Vay, M., Meyer, M. J., Blank, A., Skopp, G., Rose, P., Tzvetkov, M. V., & Mikus, G. (2020). Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial. Clin Pharmacokinet.
Chicago Style aipamenaVay, Manuela, Marleen Julia Meyer, Antje Blank, Gisela Skopp, Peter Rose, Mladen Vassilev Tzvetkov, and Gerd Mikus. "Oral Yohimbine As a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial." Clin Pharmacokinet 2020.
MLA aipamenaVay, Manuela, et al. "Oral Yohimbine As a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial." Clin Pharmacokinet 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.